The Economic Burden of Abuse of Prescription Opioids: A Systematic Literature Review from 2012 to 2017

Marcia Reinhart, Lauren M. Scarpati, Noam Y. Kirson (), Cody Patton, Nina Shak and Jennifer G. Erensen
Additional contact information
Marcia Reinhart: Analysis Group, Inc.
Lauren M. Scarpati: Analysis Group, Inc.
Noam Y. Kirson: Analysis Group, Inc.
Cody Patton: Analysis Group, Inc.
Nina Shak: Analysis Group, Inc.
Jennifer G. Erensen: Purdue Pharma L.P.

Applied Health Economics and Health Policy, 2018, vol. 16, issue 5, No 4, 609-632

Abstract: Abstract Background Abuse of prescription opioids [opioid use disorder (OUD), poisoning, and fatal and non-fatal overdose] is a public health and economic challenge that is associated with considerable morbidity and mortality in the USA and globally. Objective To systematically review and summarize the health economics literature published over the last 5 years that describes the economic burden of abuse of prescription opioids. Methods Findings from searches of databases including MEDLINE, Embase, and Cochrane CENTRAL as well as hand searches of multiple conference abstracts were screened against predefined inclusion criteria to identify studies reporting cost and healthcare resource utilization (HRU) data associated with abuse of prescription opioids. Results A total of 49 unique studies were identified. Most of the studies examined direct costs and HRU, which were substantially higher for abusers of prescription opioids than non-abuser controls in several matched cohort analyses (US$20,343–US$28,718 vs US$9716–US$14,079 for mean direct combined annual healthcare costs reported in 6 studies). Although only a small number of studies reported indirect costs, these findings suggest a high societal burden related to productivity losses, absenteeism, morbidity, and mortality among those who abuse opioids. Studies of medication-assisted treatment demonstrated that factors such as adherence, dose, formulation (film or tablet), and relapse during treatment, were associated with direct costs and HRU among treated patients. Conclusions This systematic literature review shows that abuse of prescription opioids is characterized by substantial direct healthcare costs, medical utilization, and related societal costs. Future research should further investigate the indirect costs of opioid abuse.

Date: 2018
References: View complete reference list from CitEc
Citations: View citations in EconPapers (4)

Downloads: (external link)
http://link.springer.com/10.1007/s40258-018-0402-x Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:aphecp:v:16:y:2018:i:5:d:10.1007_s40258-018-0402-x

Ordering information: This journal article can be ordered from
http://www.springer.com/economics/journal/40258

DOI: 10.1007/s40258-018-0402-x

Access Statistics for this article

Applied Health Economics and Health Policy is currently edited by Timothy Wrightson

More articles in Applied Health Economics and Health Policy from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().